Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-05-04

Clinical Trial Update: Oligofructose-enriched Inulin for the Treatment of Mild to Moderate Active Ulcerative Colitis [NA]

View source ↗

Summary

A completed clinical trial evaluated oligofructose-enriched inulin for the treatment of mild to moderate active ulcerative colitis, led by the University of Alb…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Oligofructose-enriched inulin (oligofructose-enriched inulin)

Snippet

Sponsor: University of Alberta | Conditions: Ulcerative Colitis | NA | Status: COMPLETED